The FDA-approved smoking cessation pill, varenicline, has emerged as a promising solution for young individuals grappling with nicotine addiction and the challenge of quitting vaping.In a groundbreaking study, teens and young adults taking this medication demonstrated over three times the success rate in quitting vaping compared to those receiving only behavioral counseling.